Fennema H, van den Hoek A, van der Heijden J, Batter V, Stroobant A
Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands.
AIDS. 2000 Sep 8;14(13):1993-2001. doi: 10.1097/00002030-200009080-00016.
To determine trends in (1) HIV testing and knowledge of current serostatus and (2) clinic-visits of aware HIV-infected patients and (3) to determine associates of incident HIV infection among patients with sexually transmitted disease (STD) in 15 countries participating in a European Community anonymous HIV seroprevalence survey.
Demographics, STD diagnosis, self-reported history of HIV tests and current HIV test results were collected for patients diagnosed with one of 12 pre-selected STDs. Incident HIV infections were determined among patients who reported prior HIV-negative test results.
Between June 1990 and December 1996, 66560 STD patients were tested for HIV. Of these, 1581 (2.4%) reported a prior HIV-positive test. Of 41727 (62%) patients who reported no previous HIV test, 611 (1.4%) were HIV infected. Of 20785 (31%) patients who reported a prior HIV-negative test, 213 (1.0%) were HIV infected. Of 2467 (4%) patients without prior HIV test data available 123 (4.9%) were HIV infected. Overall, 63% of HIV-seropositive patients was aware of their HIV infection. Over time, the proportion of aware HIV-seropositive patients increased in some exposure categories in south and central Europe. Among the 11684 patients who reported dates of prior HIV-negative tests, 108 HIV infections were found. Compared with the north, HIV incidence was higher in the central region [odds ratio (OR), 1.23; 95% confidence interval (CI), 0.71-2.12] and in the south (OR, 4,39; 95% CI, 2.80-6.88) in all exposure categories except homosexual men.
Two-thirds of patients with an STD had never been tested for HIV. Of all HIV infections found, 32% were undiagnosed, indicating missed opportunities for counselling, safe sex education and referral for treatment. HIV testing should be routinely offered to all STD patients.
确定参与欧洲共同体匿名艾滋病毒血清流行率调查的15个国家中,(1)艾滋病毒检测及对当前血清学状态的知晓情况、(2)已知感染艾滋病毒患者的门诊就诊情况的趋势,以及(3)确定性传播疾病(STD)患者中艾滋病毒感染的相关因素。
收集被诊断患有12种预先选定的性传播疾病之一的患者的人口统计学资料、性传播疾病诊断、自我报告的艾滋病毒检测史及当前艾滋病毒检测结果。在报告先前艾滋病毒检测结果为阴性的患者中确定新发艾滋病毒感染情况。
1990年6月至1996年12月期间,66560例性传播疾病患者接受了艾滋病毒检测。其中,1581例(2.4%)报告先前艾滋病毒检测呈阳性。在41727例(62%)报告以前未进行过艾滋病毒检测的患者中,611例(1.4%)感染了艾滋病毒。在20785例(31%)报告先前艾滋病毒检测呈阴性的患者中,213例(1.0%)感染了艾滋病毒。在2467例(4%)没有先前艾滋病毒检测数据的患者中,123例(4.9%)感染了艾滋病毒。总体而言,63%的艾滋病毒血清阳性患者知晓自己感染了艾滋病毒。随着时间的推移,在南欧和中欧的一些暴露类别中,知晓自己感染艾滋病毒的血清阳性患者比例有所增加。在报告先前艾滋病毒检测阴性日期的11684例患者中,发现了108例艾滋病毒感染。与北部相比,除男同性恋者外,中部地区[比值比(OR),1.23;95%置信区间(CI),0.71 - 2.12]和南部地区(OR,4.39;95%CI,2.80 - 6.88)在所有暴露类别中的艾滋病毒发病率均较高。
三分之二的性传播疾病患者从未接受过艾滋病毒检测。在所有发现的艾滋病毒感染中,32%未被诊断出来,这表明在咨询、安全性行为教育和转诊治疗方面存在错失的机会。应常规为所有性传播疾病患者提供艾滋病毒检测。